Axsome Therapeutics Ownership | Who Owns Axsome Therapeutics?


OverviewForecastRevenueFinancialsChartTranscripts

Axsome Therapeutics Ownership Summary


Axsome Therapeutics is owned by 77.17% institutional investors, 17.06% insiders, and 5.77% retail investors. Rtw investments, lp is the largest institutional shareholder, holding 8.42% of AXSM shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.69% of its assets in Axsome Therapeutics shares.

AXSM Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAxsome Therapeutics77.17%17.06%5.77%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Rtw investments, lp4.05M8.42%$342.79M
Vanguard group3.90M8.11%$330.19M
Blackrock funding, inc. /de3.53M7.34%$298.96M
Blackrock3.30M6.96%$265.65M
Fairmount funds management1.47M3.05%$124.29M
Bvf inc/il1.39M2.88%$117.44M
Fmr1.00M2.08%$84.65M
Ra capital management1.00M2.08%$84.61M
Macquarie group964.05K2.00%$81.57M
State street947.25K1.97%$80.15M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Alethea capital management734.32K53.19%$62.13M
Fairmount funds management1.47M12.36%$124.29M
Checkpoint capital174.77K7.53%$14.79M
Rtw investments, lp4.05M5.18%$342.79M
Ally bridge group (ny)66.66K4.84%$5.64M
Tri locum partners lp249.77K4.38%$21.13M
Svb capital management33.85K4.12%$2.86M
Bvf inc/il1.39M3.98%$117.44M
Ghost tree capital150.00K3.78%$12.07M
Sofinnova investments491.73K3.03%$41.60M

Top Buyers

HolderShares% AssetsChange
Lazard asset management537.67K0.07%451.74K
Norges bank403.03K0.00%403.03K
Bvf inc/il1.39M3.98%342.06K
Principal financial group207.06K0.01%203.67K
Raymond james financial174.59K0.01%174.59K

Top Sellers

HolderShares% AssetsChange
Fairmount funds management1.47M12.36%-891.09K
Deep track capital, lp---857.22K
Morgan stanley321.98K0.00%-621.90K
Adage capital partners gp60.00K0.01%-465.00K
Point72 asset management185.14K0.03%-357.48K

New Positions

HolderShares% AssetsChangeValue
Norges bank403.03K0.00%403.03K$34.10M
Raymond james financial174.59K0.01%174.59K$14.77M
Man group163.39K0.04%163.39K$13.82M
Marshall wace, llp127.10K0.01%127.10K$10.75M
Cubist systematic strategies116.94K0.06%116.94K$9.89M

Sold Out

HolderChange
Financial gravity asset management-1.00
Geowealth management-5.00
Allspring global investments-9.00
Capital performance advisors llp-10.00
Nelson, van denburg & campbell wealth management group-10.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20243193.57%37,149,265-2.97%771.22%15315.04%90-1.10%
Sep 30, 202430712.45%38,233,493-6.12%791.08%13115.93%93-1.06%
Jun 30, 2024271-3.21%40,700,3596.09%851.20%112-17.04%9317.72%
Mar 31, 20242806.87%38,362,452-0.55%841.26%13520.54%79-11.24%
Dec 31, 20232627.82%38,574,2922.46%811.10%1121.82%8917.11%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF1.31M2.69%114.89K
Vanguard Total Stock Mkt Idx Inv1.25M2.56%876.00
Vanguard Small Cap Index989.85K2.03%798.00
iShares Russell 2000 ETF968.14K1.99%-8.41K
Vanguard Institutional Extnd Mkt Idx Tr617.91K1.27%3.34K
Delaware Small Cap Core I579.64K1.21%-3.59K
Macquarie Small Cap Core I579.64K1.19%-
Vanguard Small Cap Growth Index Inv556.13K1.14%-3.12K
Bellevue Healthcare Ord506.57K1.06%506.57K
Eventide Gilead N439.57K0.90%-

Recent Insider Transactions


DateNameRoleActivityValue
Feb 14, 2025Pizzie Nick Chief Financial OfficerSell$393.21K
Feb 13, 2025Pizzie Nick Chief Financial OfficerSell$1.56M
Sep 11, 2024Saad Mark E-Sell$1.01M
Aug 09, 2024Jacobson Mark L. Chief Operating OfficerSell$4.02M
May 29, 2024Jacobson Mark L. Chief Operating OfficerSell$587.81K

Insider Transactions Trends


DateBuySell
2025 Q1-2
2024 Q4--
2024 Q3-2
2024 Q2-4
2024 Q1-2

AXSM Ownership FAQ


Who Owns Axsome Therapeutics?

Axsome Therapeutics shareholders are primarily institutional investors at 77.17%, followed by 17.06% insiders and 5.77% retail investors. The average institutional ownership in Axsome Therapeutics's industry, Biotech Stocks , is 68.48%, which Axsome Therapeutics exceeds.

Who owns the most shares of Axsome Therapeutics?

Axsome Therapeutics’s largest shareholders are Rtw investments, lp (4.05M shares, 8.42%), Vanguard group (3.9M shares, 8.11%), and Blackrock funding, inc. /de (3.53M shares, 7.34%). Together, they hold 23.86% of Axsome Therapeutics’s total shares outstanding.

Does Blackrock own Axsome Therapeutics?

Yes, BlackRock owns 6.96% of Axsome Therapeutics, totaling 3.3M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 265.65M$. In the last quarter, BlackRock increased its holdings by 104.5K shares, a 3.27% change.

Who is Axsome Therapeutics’s biggest shareholder by percentage of total assets invested?

Alethea capital management is Axsome Therapeutics’s biggest shareholder by percentage of total assets invested, with 53.19% of its assets in 734.32K Axsome Therapeutics shares, valued at 62.13M$.

Who is the top mutual fund holder of Axsome Therapeutics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Axsome Therapeutics shares, with 2.69% of its total shares outstanding invested in 1.31M Axsome Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools